Cytodyn Inc (CYDY)

[The Lawman]

In order to salvage the company, and get approval for a promising drug, Pourhassan needs to be replaced NOW.

This is the same Pourhassan who sold most of his stock (none of which he purchased) at much higher prices, netting him around $15 million, while telling shareholders the share price would go to triple digits.

This is the same Pourhassan who was roundly criticized by a Delaware judge, rebuked by the FDA, and is the subject of current investigations by the SEC and DOJ.

While the company is on financial life support, Pourhassan continues to receive a $10 million compensation package, which is higher than CEO's of many prominent and highly profitable companies.

If Pourhassan will not resign, and if he is not forced out by the SEC or DOJ, the shareholders need to band together and convene an emergency meeting in which Pourhassan is ousted, along with Kelly.

For $10 million a year, Cytodyn could replace Pourhassan with a seasoned biopharma CEO who has a track record of successfully turning around distressed companies.

My opinions, for what they are worth.

LM